Health Trials

Low Grade Non-Hodgkin's Lymphoma, Adult

2

Review clinical trials related to Low Grade Non-Hodgkin's Lymphoma, Adult. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Epcoritamab and Rituximab for First-line Follicular Lymphoma

The purpose of this study is to determine how effective and safe the combination of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma. The names of the study drugs involved in this study are: * Rituximab (a type of monoclonal antibody therapy) * Epcoritamab (a T-cell bispecific antibody)

Participants needed: 100
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Reid Merryman, MDUpdated: May 22, 2026Locations: 6
Eligibility criteria

Histologically confirmed diagnosis of CD20+ FL (grade 1-3A) with review of the d... [+25]

Patients who require systemic immunosuppressive therapy for an ongoing medical c... [+27]

Read more
Status: Recruiting

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).

Participants needed: 150
Trial details
Age: 70+Biological sex: AllType: ObservationalSponsor: Fondazione Italiana Linfomi - ETSUpdated: Jan 12, 2026Locations: 20
Eligibility criteria

Local histological diagnosis of indolent B cell non-Hodgkin lymphoma: follicular... [+5]

none

Read more